Cottineau C, Bukowski J G, Subayi L B, Hassoun S, Drouet M
Département d'Anesthésie-Réanimation Chirurgicale B-C.H.U., Angers, France.
Allerg Immunol (Paris). 1998 May;30(5):143-8.
When peri-anaesthesia anaphylactic and/or anaphylactoid reactions occur, anaesthetist is the first investigator: the quality of immuno-allergological investigations depends on these initial investigational procedures. We have used sample kits for several years in order to make easier the immediate investigation. From retrospective analysis of the allergic complications which happened in 1997, the importance of these sample kits as well as the anaesthetist's part in the immuno-allergological management are examined. Nine observations were itemized (0.047%): 3 generalized erythema observations (grade I), in which atracurium was incriminated twice, and propacetamol once; 2 observations of grade II, in which vecuronium (elevated tryptase) and atracurium were incriminated; 4 anaphylactic shocks, in which three neuromuscular blocking drugs (suxamethonium, vecuronium and pancuronium), and one antibiotic (cloxacilline) were incriminated. The use of sample kits allowed an early diagnosis approach, confirmed by skin tests. Diagnosis should be thought closely between anaesthetists and immunologists for investigations.
当围麻醉期发生过敏和/或类过敏反应时,麻醉医生是首要调查者:免疫过敏学调查的质量取决于这些初始调查程序。为了便于即时调查,我们使用样本试剂盒已有数年。通过对1997年发生的过敏并发症进行回顾性分析,研究了这些样本试剂盒的重要性以及麻醉医生在免疫过敏学处理中的作用。详细列出了9例观察病例(0.047%):3例全身性红斑观察病例(I级),其中阿曲库铵被认定为病因两次,丙帕他莫被认定为病因一次;2例II级观察病例,其中维库溴铵(类胰蛋白酶升高)和阿曲库铵被认定为病因;4例过敏性休克,其中三种神经肌肉阻滞药物(琥珀胆碱、维库溴铵和泮库溴铵)和一种抗生素(氯唑西林)被认定为病因。样本试剂盒的使用使得能够采用早期诊断方法,并通过皮肤试验得到证实。麻醉医生和免疫学家应密切合作进行调查诊断。